A Pipeline Win as BridgeBio Learns to Balance Theory with Practice

Neil Kumar, co-founder and CEO of BridgeBio, discusses the approval of its ATTR-CM therapy Attruby, the company’s late-stage pipeline, and what he’s learned about its business model in the process.

Om Podcasten

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.